Insider Transactions in Q4 2021 at Nautilus Biotechnology, Inc. (NAUT)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2021
|
Parag Mallick Chief Scientist |
SELL
Bona fide gift
|
Direct |
210,000
-1.02%
|
-
|
|
Dec 08
2021
|
Perceptive Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
200,000
+2.15%
|
$1,000,000
$5.36 P/Share
|
|
Dec 01
2021
|
Sujal M Patel CEO, President, and Secretary |
BUY
Open market or private purchase
|
Direct |
88,022
+0.88%
|
$352,088
$4.73 P/Share
|
|
Dec 01
2021
|
Matthew L. Posard Director |
BUY
Open market or private purchase
|
Direct |
30,000
+20.56%
|
$120,000
$4.47 P/Share
|
|
Nov 30
2021
|
Sujal M Patel CEO, President, and Secretary |
BUY
Open market or private purchase
|
Direct |
161,978
+1.63%
|
$647,912
$4.72 P/Share
|
|
Nov 30
2021
|
Matthew L. Posard Director |
BUY
Open market or private purchase
|
Direct |
20,000
+50.0%
|
$80,000
$4.57 P/Share
|
|
Nov 24
2021
|
Anna Mowry CFO and Treasurer |
BUY
Open market or private purchase
|
Direct |
15,000
+31.58%
|
$60,000
$4.58 P/Share
|
|
Nov 15
2021
|
Matthew S Mc Ilwain Director |
BUY
Open market or private purchase
|
Direct |
100,000
+17.89%
|
$500,000
$5.3 P/Share
|